At this stage, our options in SA are limited to methylphenidate, atomoxetine and bupropion. We are waiting for SAPHRA to approve lisdexamphetamine.
The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal
advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.